Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASN51 drug-drug interaction pharmacokinetics study with fluvoxamine, itraconazole, and paroxetine in healthy adults
NL-OMON60726Phase 1Completed
- Sponsor
- Asceneuron SA
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of ASN51 (3 arms), sponsored by Asceneuron SA. Primary endpoint: Primary endpoint(s) not publicly disclosed. Started Feb 2024; status: completed.
02
Drugs
ASN51
Beyond the preview
Go deeper on NL-OMON60726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60726.